SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Cronos Grows its International Footprint in Switzerland

    By

    Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training.

    “We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, President and CEO, Cronos. “This partnership aligns with our mission to provide borderless cannabis products to European medical markets. Expanding our presence in Europe is an important area of focus for Cronos’ growth, and through this collaboration, we will leverage Dascoli’s strong local presence to better serve the needs of patients.”

    Under the agreement, Cronos will supply PEACE NATURALS®-branded cannabis flower to Dascoli for distribution across its established medical network in Switzerland. This strategic collaboration marks another step in Cronos’ international growth strategy and strengthens its presence in key emerging medical cannabis markets.

    The following PEACE NATURALS® flower will be available:

    • GMO Cookies
    • Space Cake
    • Atomic Sour Grapefruit
    • Sonic Lemon Fuel
    • Wedding Cake

    PEACE NATURALS® medical cannabis products also recently launched in Australia and Malta. The brand is now available for patients in Australia, Canada, Germany, Israel, Malta, Switzerland and the UK.

    10 June 2026 · Berlin Sales end May 29

    European Cannabis
    Insights Summit

    From €216

    200+ industry leaders. Exclusive German market data. A half-day briefing for B2B operators in Europe's most important emerging cannabis market.

    Ben Stevens

    Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free